StockData
Compugen Ltd logo

Compugen Ltd (CGEN) stock

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30
$1.96−0.06 (-2.97%)

Close on Nov 18, 2026Market cap $185.32MP/E 5.2Yield –

Compugen revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $72.76M, up 161.1% from the year before. Over ten years it grew 35.3% a year on average. The highest annual figure on record is $72.76M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$72.76M+161.1%
FY2024Dec 31, 2024$27.86M-16.7%
FY2023Dec 31, 2023$33.46M+346.1%
FY2022Dec 31, 2022$7.50M+25.0%
FY2021Dec 31, 2021$6.00M+200.0%
FY2020Dec 31, 2020$2.00M-88.8%
FY2018Dec 31, 2018$17.80M+2400.0%
FY2016Dec 31, 2016$712.00K-92.3%
FY2015Dec 31, 2015$9.28M-25.0%
FY2014Dec 31, 2014$12.37M+248.5%
FY2013Dec 31, 2013$3.55M+1366.5%
FY2012Dec 31, 2012$242.00K-78.3%
FY2010Dec 31, 2010$1.12M+346.0%
FY2009Dec 31, 2009$250.00K–

More Compugen figures

See a number that looks wrong?